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Objective: To evaluate the efficacy of common antiseptic mouth rinses and octenidine dihy-
drochloride (OCT).
Methods: The antibacterial activities of antiseptics against total and cariogenic bacteria (Strep-
tococcus mutans and Lactobacillus species) in saliva were studied in vitro and in vivo. After
unstimulated saliva was collected, one of the mouth rinse solutions was applied for 30 seconds.
Saliva sampleswere collected 15, 30, 60, and 120 min later and evaluated for their bacterial count.
Results: OCT had a significantly greater inhibitory effect on the studied bacteria than 0.2%
chlorhexidine gluconate (CHX) and 7.5% polyvinylpyrrolidone—iodine complex (PVP—I) from
15 min to 120 min following the application (p < 0.01). The antiseptic efficacy of 0.2% CHX on
total bacteria and Lactobacillus species was very similar to the efficacy observed with 7.5% PVP—I
mouth solution from 15 min up to 120 min. Streptococcus mutans was completely inhibited by
0.15 mg/ml PVP—I, 0.5 mg/ml CHX, and 0.1 mg/ml OCT concentrations, while Streptococcus
salivarius was inhibited by 0.15 mg/ml PVP—I, 2 mg/ml CHX, and 0.8 mg/ml OCTconcentrations.
Lactococcus lactis subspecies lactis was inhibited with 0.00313 mg/ml OCT, 30 mg/ml PVP—I, and
0.0063 mg/ml CHX concentrations.
Conclusions: OCTcompared favorably with CHX and PVP—I in its antibacterial effects, both in vitro
and in vivo (p < 0.01).
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.6 2113374; fax: +90 246 2370607.
.com (A.A. Dogan).
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Fixed orthodontic appliances are considered to be a clinical
risk factor in terms of enamel integrity because of plaque
accumulation around the bracket bases.1 The placement of
orthodontic appliances generally hinders good oral hygiene,
and the appliance components can cause alterations in the
oral microflora by reducing pH and increasing retention areas
for microorganisms.2,3 Increased levels of Streptococcus
mutans and Lactobacillus species have been detected in
the oral cavity and saliva after bonding orthodontic attach-
ments.2,4,5 These microorganisms have been identified as the
main pathogens in dental caries, and their presence increases
the risk for decalcification.5
Patient success in maintaining proper hygiene appears to
be limited by the patient’s inability to reach certain plaque-
infected sites because of the appliances used during ortho-
dontic treatment. Hence, there currently exists a great need
for the development of antibacterial chemotherapeutic
agents to assist in the control of dental plaque-associated
infections in humans.6,7 Some antibacterial agents are able
to permeate the plaque matrix and rapidly kill pathogenic
bacteria, thereby helping to reduce the destructive effect of
microorganisms that create an acidic medium in the mouth.
Octenidine dihydrochloride (OCT) is one such a product
hypothesized to be capable of exerting beneficial in vitro
and in vivo effects on cariogenic bacteria.8,9
Slee and O’Connor et al.8 selected OCT (Sterling-Winthrop
Research Institute, Rensselaer, NY, USA) from a series of
bispyridine analogues that had been screened for antimicro-
bial activity against S. mutans, Streptococcus sanguis, Acti-
nomyces viscosus, and Actinomyces naeslundii for their
study. These investigators found octenidine to exhibit dur-
ability, and identified the minimum inhibitory concentration
(MIC) as being 0.05 mg/ml in an aqueous solution. In rats,
Shern et al.9 showed that 0.5% OCTwas almost as effective in
decreasing plaque scores as 0.5% chlorhexidine gluconate
(CHX), while Emilson et al.10 found that 1% OCT reduced
plaque scores in monkeys significantly better than 1% CHX.
Because both the absolute (compared to physiological
saline (PS)) and relative (compared with CHX and polyvinyl-
pyrrolidone—iodine (PVP—I)) antibacterial effects of OCT in
saliva have already been established, the current study was
conducted to assess the short-term (up to 120 min) effect of
the newly developed Octenisept1 (Schu¨lke & Mayr, Norder-
stedt, Germany) containing 0.1% OCT, on total salivary bac-
terial count and cariogenic bacteria,mainly S.mutansand oral
Lactobacillus species, inorthodontically treatedpatients. This
is because salivary cariogenic bacteria are one of the initiators
of enamel decalcification and smooth surface caries in ortho-
donticpatients.10 Inaddition, its effectwas comparedwith the
more commonly used CHX (0.2% chlorhexidine gluconate) and
with PVP—I containing 7.5% poly(1-vinyl-2-pyrrolidone) iodine
as its active ingredient.
Materials and methods
Experimental design
The absolute and relative antibacterial activities of OCT
against total and cariogenic bacteria (S. mutans and Lacto-bacillus species) in saliva were studied both in vitro and
in vivo.
In vitro tests
The in vitro effect of the mouth rinsing solutions was deter-
mined by the MIC of each rinsing solution with S. mutans
(ATCC 27351/27951), Streptococcus salivarius (ATCC 25975),
and Lactococcus lactis subspecies lactis strains, studied with
a broth dilution method. Serial dilutions of 0.1% OCT, 0.2%
CHX, and 7.5% PVP—I were prepared in trypticase soy broth.
An overnight inoculum of 0.1 ml S. mutans, S. salivarius, and
Lactococcus lactis subspecies lactis strains adjusted to 0.5
McFarland turbidity were added to each test tube. The test
tubes were incubated at 37 8C overnight in a 5% CO2 atmo-
sphere for the first two strains and in anaerobic conditions for
the latter. After the incubation period, a quantity of 0.001 ml
was taken from each test tube and inoculated on a blood agar
plate surface for the observation of any bacterial growth. In
addition, the colony count was measured after an overnight
incubation.
In vivo tests
The sample consisted of 18 patients (five male) aged 12 to 16
years selected from patients who were starting their ortho-
dontic treatment at the Department of Orthodontics, Suley-
man Demirel University, Isparta, Turkey. The research project
was approved by the Ethics Committee of Suleyman Demirel
University Medical Faculty. Written informed consent was
obtained from each subject on a voluntary basis, with the
option that the participants could withdraw from the study
for any reason at any time, without affecting their ortho-
dontic treatment. All patients were scheduled for full-
bonded edgewise treatment with metal brackets on their
anterior teeth and premolars and bands on their molars with
0.014 NiTi arc wire for leveling. None of the subjects had
received antibiotics or topical antiseptics during the previous
30 days or had systemic diseases that could alter the amount
or composition of their plaque or saliva. The study began the
day after bonding the brackets and bands and lasted for 2
months with follow-up at 2-week intervals.
The volunteers were asked to collect 2—3 ml of unstimu-
lated saliva in themorning immediatelybefore themouth rinse
application as a baseline sample, and again at 15, 30, 60, and
120 min after one of the mouth rinse solutions had been used
for 30 seconds. The volunteers were asked to brush their teeth
the day before, after dinner, without toothpaste and to avoid
eating breakfast and brushing in the morning. During the
course of the experiment the volunteers were asked to refrain
from drinking and eating between 9 and 11 a.m. One of the
three mouth rinse solutions and a PS solution as control were
applied for 30 seconds at each application (as per Lundstrom
and Krasse11). The solutions used were: Octenisept (Schu¨lke &
Mayr, Norderstedt, Germany), Klorhex (Drogsan, Ankara, Tur-
key), and Batticon (Adeka, Samsun, Turkey), and a PS solution.
The experiment was performed on the same patient
for each mouth rinse solution separately at 2-week intervals.
At the beginning of each phase, the plaque scores of all
subjects were brought to approximately identical levels
with a thorough dental prophylaxis. A dental prophylaxis
Oral antibacterial effect of octenidine dihydrochloride e21was completed before the next mouth rinse solution was
used. Thus, a week interval was applied between rinses.
All the samples were taken to and processed at the
microbiology laboratory of the medical faculty in sterile
conditions within 30 min, and stored at +4 8C until proces-
sing. After vortexing, a 10 ml aliquot of each saliva sample
was diluted 1:10 000 with PS. The dilutions were established
by our preliminary study in which suitable dilution ratios of
the saliva samples for observing countable colony-forming
units (cfu) on agar plates were determined. The original
data, measured in cfu, were transformed to log(10) for
statistical analysis and reported as log(cfu).
Mitis salivarius agar (Difco Laboratories, MD, USA) supple-
mented with 15% sucrose and bacitracin (0.2 U per ml of
medium; MS-SB) and Rogosa agar (Oxoid, Basingstoke, Hamp-
shire, UK), which are selective media for S. mutans12 and for
lactobacilli, respectively, were used.13 Total viable counts of
all cultivable facultative anaerobic and anaerobic bacteria
were made on trypticase soy agar enriched with 5% (v/v)
sheep blood.
Incubation of the samples was performed in an anaerobic
atmosphere at 37 8C for 48 hours. After incubation, the total
cfu on each plate were counted. Plates selectively inoculated
for S. mutans and Lactobacillus species were incubated in the
same gaseous mixture, then allowed to develop at room
temperature for 24 hours to enhance colony development.
Total viable counts for each bacterial species were morpho-
typed. Fine opaque, pale yellow colonies on Rogosa agar with
Gram-positive, non-spore forming, and catalase-negative
rods were further confirmed by positive indole and negative
motility tests, and were considered to be Lactobacillus
species.14 Colonies growing on MS-SB agar with catalase-
negative and Gram-positive cocci in chains on microscopy
were considered to be S. mutans.
Statistical analysis
The statistical analyses were performed using SPSS (Windows
version 12.0; Chicago, USA) software. The values of repeatedTable 1 In vitro antibacterial activities of octenidine dihydrochlo
idine gluconate (CHX) for Streptococcus mutans, Streptococcus sali
Concentration
mg/ml
Streptococcus
mutans cfu/ml
OCT 0.8 ()
0.4 ()
0.2 ()
0.1 ()
0.05 1
PVP—I 0.15 ()
0.075 2.102
0.050 6.102
0.025 103
0.0125 6.104
CHX 2 ()
1 ()
0.5 ()
0.25 8.102
0.125 1.103
Control 2.107bacterial count (cfu/ml) after PS, OCT, CHX, and PVP—I
mouth rinsing were expressed as the minimum (min), max-
imum (max), and median. The bacterial count differences in
median ranks for repeated measures among time intervals
(before mouth rinsing (T0), 15-min effect (T1), 30-min effect
(T2), 60-min effect (T3), 120-min effect (T4)) were compared
by the non-parametric Friedman test, and significance levels
were set at 0.05. The Wilcoxon signed ranks test was used to
compare two dependent non-parametric values, and the
significance level was chosen as 0.01, according to Bonferroni
adjustment. The Friedman test was used to determine the
bacterial count difference at each time interval for the
different mouth rinsing solutions, and the Wilcoxon sign rank
test was used for two dependent non-parametric values.
Again, a significance level of 0.01 was chosen.
Results
In vitro results
S. mutans was completely inhibited with the 0.15 mg/ml
PVP—I complex, 0.5 mg/ml CHX, and 0.1 mg/ml OCTconcen-
trations, while S. salivarius was inhibited by the 0.15 mg/ml
PVP—I, 2 mg/ml CHX, and 0.8 mg/ml OCT concentrations
(Table 1). In addition, Lactococcus lactis subspecies lactis
was completely inhibited at every tested concentration of
OCTand CHX, but it grew at every concentration of the PVP—I
complex tested. For this reason new concentrations were
evaluated in a second stage for the antiseptic mouth rinses
with Lactococcus lactis subspecies lactis. The results are
shown in Table 2. Higher concentrations of PVP—I and lower
concentrations of OCTand CHX were evaluated to determine
the MIC of these solutions for Lactococcus lactis subspecies
lactis (Table 2). MIC values of OCT, PVP—I, and CHX were
determined as 0.003, 30, and 0.006 mg/ml, respectively, for
Lactococcus lactis subspecies lactis.
The activities of CHX and OCT on Lactococcus lactis sub-
species lactis were significantly higher when compared with
their effects on S. mutans and S. salivarius. On the otherride (OCT), polyvinylpyrrolidone—iodine (PVP—I), and chlorhex-
varius, and Lactococcus lactis subspecies lactis
Streptococcus
salivarius cfu/ml
Lactococcus lactis
subspecies lactis cfu/ml
() ()
1 ()
8 ()
20 ()
103 ()
() 106
2.102 4.106
7.102 7.106
103 107
7.103 2.107
() ()
2.102 ()
4.102 ()
103 ()
6.103 ()
2.107 3.108
Table 2 In vitro antibacterial activities of octenidine dihy-
drochloride (OCT), polyvinylpyrrolidone—iodine (PVP—I), and
chlorhexidine gluconate (CHX) for Lactococcus lactis subspecies
lactis
Concentration
mg/ml
Lactococcus lactis
subspecies lactis
cfu/ml
OCT 0.01250 ()
0.00625 ()
0.00313 ()
0.00156 103
0.00008 6.103
PVP—I 37.5 ()
30.0 ()
22.5 2.103
15.0 104
7.5 12.104
CHX 0.02500 ()
0.01250 ()
0.00625 ()
0.00313 8.103
0.00156 2.104
Control 3.108
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inhibit the growth of Lactococcus lactis subspecies lactis
when compared with other strains.
In vivo results
OCT had a significantly stronger impact on the microbial
burden of the oral cavity than CHX beginning at 15 min
post-application. PVP—I and CHX were significantly less
effective compared with 0.1% OCT from the beginning to
up to 120 min ( p < 0.01). The antiseptic efficacy of 0.2% CHXTable 3 Antibacterial effects of different mouth rinse solutions fo
Timea
T0—T1 T0—T2 T0—
Total bacteria PS NS NS NS
OCT <0.001 <0.001 <0.0
CHX <0.001 <0.001 <0.0
PVP—I <0.001 NS <0.0
Lactobacillus species PS NS NS NS
OCT <0.001 <0.001 <0.0
CHX <0.001 <0.001 <0.0
PVP—I NS 0.001 NS
Streptococcus mutans PS NS NS NS
OCT 0.003 <0.001 <0.0
CHX NS <0.001 <0.0
PVP—I 0.008 0.003 0.00
p-Values based on Wilcoxon test.
NS: not significant; PS: physiological saline; OCT: octenidine dihydrochl
iodine.
a T0: before mouth rinsing; T1: effect at 15 min; T2: effect at 30 minon total bacteria and Lactobacillus species was very similar to
the efficacy observed with 7.5% PVP—I mouth solution from
the beginning of the antiseptic treatment to up to 120 min. In
contrast, the antiseptic efficacy of 0.2% CHX on S. mutans
was superior to the efficacy observed with the 7.5% PVP—I
solution from the beginning of the antiseptic treatment to up
to 120 min. The antimicrobial impact of CHX was very similar
to PVP—I. Comparison of different mouth rinse solutions on
antibacterial effects for each time interval and comparisons
between the antiseptics are presented in Tables 3 and 4,
respectively. Cfu—time graphs of total bacteria, Lactobacil-
lus species, and S. mutans are presented in Figures 1, 2,
and 3, respectively.
Discussion
The levels of cariogenic pathogens should be constantly
reduced during orthodontic treatment. To achieve a fast
reduction in cariogenic bacteria, primary dental care begins
at home. Orthodontic treatment requires high levels of
patient compliance; this is a problem especially in teenagers,
an age group in which compliance is generally low. Practicing
satisfactory oral hygiene, such as adequate tooth brushing,
mouth rinsing, chewing gums, dental flossing, and using
sustained release varnishes all play a vital role in maintaining
healthy teeth throughout orthodontic treatment.15—17
However, only a few studies have been done with a novel
oral antiseptic mouth rinse solution, OCT, to test its con-
tribution to oral hygiene by determining its quantitative
effects on S. mutans, Lactobacillus species, and total bac-
teria. For this reason, we aimed to determine the reduction
or elimination of the cariogenic bacteria that cause smooth
surface caries and white spots during orthodontic treatment,
with this mouth rinse. Initially, we began detecting MIC
activities of OCT, PVP—I, and CHX for S. mutans and Lacto-
bacillus species, which are highly associated with caries.18,19
Reduction of these bacteria from the oral cavity is a crucialr each time interval
T3 T0—T4 T1—T2 T1—T4 T3—T4 T1—T3
T2—T3
T2—T4
NS NS NS NS NS
01 <0.001 NS 0.007 0.002 NS
01 <0.001 <0.001 NS NS NS
01 <0.001 NS NS NS NS
NS NS NS NS NS
01 <0.001 NS NS NS NS
01 <0.001 NS NS NS NS
NS NS NS NS NS
NS NS NS NS NS
01 <0.001 NS NS NS NS
01 0.001 NS NS NS NS
3 0.004 NS NS NS NS
oride; CHX: chlorhexidine gluconate; PVP—I: polyvinylpyrrolidone—
; T3: effect at 60 min; T4: effect at 120 min.
Table 4 Comparison of antibacterial effects of different mouth rinse solutions for each time
Total bacteria Lactobacillus species Streptococcus mutans
Time 0 PS—OCT NS NS NS
PS—CHX NS NS NS
PS—PVP—I NS NS NS
OCT—CHX NS NS NS
OCT—PVP—I NS NS NS
CHX—PVP—I NS NS NS
Time 1 PS—OCT <0.001 <0.001 <0.001
PS—CHX NS 0.001 NS
PS—PVPI NS 0.007 NS
OCT—CHX <0.001 0.002 NS
OCT—PVP—I <0.001 0.006 NS
CHX—PVP—I NS NS NS
Time 2 PS—OCT <0.001 <0.001 <0.001
PS—CHX <0.001 0.002 0.004
PS—PVP—I NS 0.002 0.004
OCT—CHX <0.001 <0.001 <0.001
OCT—PVP—I <0.001 <0.001 <0.001
CHX—PVP—I NS NS NS
Time 3 PS—OCT <0.001 <0.001 <0.001
PS—CHX <0.001 <0.001 <0.001
PS—PVP—I 0.007 0.005 0.006
OCT—CHX <0.001 0.006 <0.001
OCT—PVP—I <0.001 <0.001 <0.001
CHX—PVP—I NS NS NS
Time 4 PS—OCT <0.001 <0.001 <0.001
PS—CHX 0.001 <0.001 0.001
PS—PVP—I 0.001 0.004 NS
OCT—CHX <0.001 <0.001 0.001
OCT—PVP—I <0.001 <0.001 0.001
CHX—PVP—I NS 0.009 NS
p-Values based on Wilcoxon tests.
NS: not significant; PS: physiological saline; OCT: octenidine dihydrochloride; CHX: chlorhexidine gluconate; PVP—I: polyvinylpyrrolidone—
iodine.
Figure 2 Cfu(log10)—time graph of Lactobacillus species for
120 min after PS (physiological saline), OCT (octenidine dihy-
drochloride), CHX (chlorhexidine gluconate), and PVP—I (poly-
vinylpyrrolidone—iodine) treatment. The p-values for the mouth
rinse solutions are as follows: PS: 0.498; OCT: <0.001; CHX:
<0.001; PVP—I: 0.003.
Figure 1 Cfu(log10)—time graph of total bacteria for 120 min
after PS (physiological saline), OCT (octenidine dihydrochlor-
ide), CHX (chlorhexidine gluconate), and PVP—I (polyvinylpyrro-
lidone—iodine) treatment. The p-values for the mouth rinse
solutions are as follows: PS: 0.914; OCT: <0.001; CHX:
<0.001; PVP—I: <0.001.
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Figure 3 Cfu(log10)—time graph of Streptococcus mutans for
120 min after PS (physiological saline), OCT (octenidine dihy-
drochloride), CHX (chlorhexidine gluconate), and PVP—I (poly-
vinylpyrrolidone—iodine) treatment. The p-values for the mouth
rinse solutions are as follows: SP: 0.018; OCT: <0.001; CHX:
<0.001; PVP—I: <0.001.
e24 A.A. Dogan et al.step in the prevention and treatment of caries. It is not
possible to predict the efficacy of a particular product if
the antimicrobial activity is determined with in vitromethods
exclusively.20 Thus, the in vivo study model was designed to
determine the absolute and relative short-term (two-hour)
effect of OCT on S. mutans, Lactobacillus species, and total
oral bacteria in orthodontically treated patients. The objec-
tive was to assess the relative antibacterial efficacy and
short-term durability of each mouth rinse solution. We chose
CHX as one of the rinses; CHX is considered to be the gold
standard because of its antibacterial effect already deter-
mined in previous studies.21—23
Even though several other studies have tested the effects
of CHX24—26 and PVP—I,27—29 the number of total and cario-
genic bacteria in saliva after rinsing with OCT has not been
tested before on orthodontically treated patients. OCT was
found to be efficacious and compared favorably with CHX and
PVP—I in its antibacterial effect in saliva. This effect con-
tinued for two hours. These results were consistent with
those of Kramer et al.,19 who reported that OCT and cetyl-
pyridinium chloride were significantly more effective than
other mouth rinsing solutions including Corsodyl1 (which
contains chlorhexidine gluconate) in their immediate value.
These researchers reported that the only drawback of OCT
use was its bitter taste.
The effect of mouth rinsing applications usually lasts 15—
30 min. We detected the effect of antibacterial agents for up
to 120 min, which Kramer et al. considered sufficient.19 Both
in vitro and in vivo results were consistent with these find-
ings. A significant reduction in S. mutans and total bacterial
counts occurred 15 min after rinsing with OCT when com-
pared with PS ( p < 0.01). However, the reduction was not
significant when CHX and PVP—I mouth rinses were compared
with PS after 15 min. Octenisept also showed the highest
antibacterial effect after 120 min, while the antibacterial
effect of CHX and PVP—I showed similarity at each time
interval but they had lower benefits than OCT over the
120-min period. Both CHX and PVP—I were still effective
after 120 min (Table 4).Slee and O’Connor8 found comparably favorable effects
of OCT compared with CHX on S. mutans, S. sanguis, A.
viscosus, and A. naeslundii with respect to overall anti-
plaque potency in vitro, whereas Samet et al.30 found that
the kinetics of OCT in killing Staphylococcus aureus
depended on its concentration but was independent of
bacterial genotype. Shern et al.31 detected similar effects
of these antibacterial agents in a rat and a monkey dental
plaquemodel.10 Our in vitro and in vivo study results support
both of the above studies.
In the in vitro study of Pitten et al.,32 PVP—I, OCT, and CHX
caused a 10- to several-fold decrease in the number of total
bacteria with different antiseptic concentrations and with
different time intervals. S. aureus, Pseudomonas aeruginosa,
Escherichia coli, Enterococcus faecium, and Candida albicans
were among the microorganisms examined. They found
cetylpyridinium-based products to be less effective and used
hydrogen peroxide as a control.
Beiswanger et al.33 found that using 0.1% OCT yielded
statistically significant lower levels of plaque, less gingivitis,
and fewer bleeding sites when compared with the control
product. The control product had a statistically significant
higher stain formation and longer prophylaxis time to remove
the stain. Thus, further studies must be performed for longer
periods, and both the beneficial and adverse effects of OCT
must be evaluated when comparing it with other antibacter-
ial agents.
Conclusions
Three different mouth rinse solutions were compared with
PS and with each other for their short-term antibacterial
effects. From the tested rinsing solutions, OCTwas found to
be the most effective in substantially reducing total salivary
and total cariogenic bacterial counts after 15, 30, 60, and
120 min ( p < 0.01). This effect was found to be significantly
different compared to PVP—I complex ( p < 0.01), but not to
CHX within these time intervals.
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